Experts review prostate cancer clinical cases and discuss approaches to treating patients with PSMA targeted therapies.
EP. 1: Initial Risk Stratification of Localized Prostate Cancer
Tanya Dorff, MD, reviews guidelines for initial risk stratification of patients with localized prostate cancer, and the choices in imaging strategies.
EP. 2: Defining PSMA-PET Scans for Prostate Cancer
Phillip J. Koo, MD, provides a detailed explanation of the process of PSMA-PET imaging scans for prostate cancer.
EP. 3: Case 1: Metastatic Castrate-Resistant Prostate Cancer
Dr Ulka Vaishampayan presents the case of a 67-year-old man with metastatic castration-resistant prostate cancer.
EP. 4: PSMA-Positive mCRPC and the VISION Trial
Experts in genitourinary oncology present data from the VISION clinical trial, studying patients with PSMA-positive metastatic castration-resistant prostate cancer.
EP. 5: Lutetium-PSMA-617 for Prostate Cancer Treatment
A discussion on the use of lutetium-PSMA-617 for prostate cancer treatment.
EP. 6: Radium-223 and the ALSYMPCA Trial
A review of data from the ALSYMPCA clinical trial on the use of radium-223 for prostate cancer treatment.
EP. 7: Case 2: Metastatic Hormone-Sensitive Prostate Cancer
Dr Tanya Dorff presents the case of a 72-year-old man with metastatic hormone-sensitive prostate cancer.
EP. 8: Reviewing Data from the CARD Trial
Tanya Dorff, MD, explains safety and efficacy data from the CARD trial.
EP. 9: mCRPC: The TheraP Trial
A review of recent data from the TheraP trial.
EP. 10: Therapy Sequencing and Patient Selection in Prostate Cancer Treatment
Experts share their thoughts on sequencing hormonal agents and patient selection for clinical trials.
EP. 11: Case 3: Metastatic Castrate-Resistant Prostate Cancer
Alicia Morgans, MD, MPH, presents the case of a 67-year-old man with metastatic castration-resistant prostate cancer.
EP. 12: Lutetium-PSMA-617 and Novel Agents in Prostate Cancer
Oncologists share some final thoughts on lutetium-PSMA-617 and novel agents to look out for in prostate cancer treatment.
2 Clarke Drive Cranbury, NJ 08512